GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 203 filers reported holding GENOMIC HEALTH INC in Q3 2018. The put-call ratio across all filers is 0.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $110,000 | -1.8% | 1,623 | -15.6% | 0.00% | 0.0% |
Q2 2019 | $112,000 | +7.7% | 1,923 | +29.8% | 0.00% | 0.0% |
Q1 2019 | $104,000 | -18.1% | 1,482 | -24.9% | 0.00% | 0.0% |
Q4 2018 | $127,000 | -8.6% | 1,973 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $139,000 | +40.4% | 1,973 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $99,000 | +147.5% | 1,973 | +56.2% | 0.00% | – |
Q1 2018 | $40,000 | -7.0% | 1,263 | 0.0% | 0.00% | – |
Q4 2017 | $43,000 | +4.9% | 1,263 | 0.0% | 0.00% | – |
Q3 2017 | $41,000 | 0.0% | 1,263 | 0.0% | 0.00% | – |
Q2 2017 | $41,000 | +2.5% | 1,263 | 0.0% | 0.00% | – |
Q1 2017 | $40,000 | +8.1% | 1,263 | 0.0% | 0.00% | – |
Q4 2016 | $37,000 | 0.0% | 1,263 | 0.0% | 0.00% | – |
Q3 2016 | $37,000 | +37.0% | 1,263 | +19.7% | 0.00% | – |
Q2 2016 | $27,000 | +3.8% | 1,055 | 0.0% | 0.00% | – |
Q1 2016 | $26,000 | -29.7% | 1,055 | 0.0% | 0.00% | – |
Q4 2015 | $37,000 | +516.7% | 1,055 | +245.9% | 0.00% | – |
Q3 2015 | $6,000 | +100.0% | 305 | +148.0% | 0.00% | – |
Q2 2015 | $3,000 | -25.0% | 123 | 0.0% | 0.00% | – |
Q1 2015 | $4,000 | – | 123 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 11,744,010 | $756,432,000 | 6.19% |
EMORY UNIVERSITY | 30,319 | $1,953,000 | 1.54% |
Copper Rock Capital Partners, LLC | 292,596 | $18,630,000 | 1.46% |
DE BURLO GROUP INC | 73,600 | $4,740,000 | 1.06% |
Eversept Partners, LP | 23,866 | $1,537,209 | 0.83% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 165,310 | $10,648,000 | 0.83% |
Aurora Investment Counsel | 20,916 | $1,347,000 | 0.73% |
Texas Children's | 8,035 | $518,000 | 0.72% |
Capital Impact Advisors, LLC | 24,665 | $1,570,000 | 0.67% |
Granahan Investment Management | 130,650 | $8,415,000 | 0.60% |